David Remillard
Impact in
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Chromatin Remodeling and Cancer
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 5
-
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 5
- Chromatin Remodeling and Cancer 2
- RNA Research and Splicing 2
- Cancer-related gene regulation 2
- Co-authors
- James E. Bradner (3 shared papers)Gerard L. Brien (2 shared papers)Scott A. Armstrong (2 shared papers)Nathanael S. Gray (3 shared papers)Hyuk‐Soo Seo (3 shared papers)Dennis L. Buckley (3 shared papers)Sirano Dhe‐Paganon (3 shared papers)Matthew Sonnett (1 shared paper)
- Journals
- Angewandte Chemie International Edition (2 papers)ACS Chemical Biology (1 paper)Journal of the American Chemical Society (1 paper)Science Advances (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesGermanyIreland
In The Last Decade
David Remillard
11 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 1.1k
- Hematology 164
- Oncology 270
- Pathology and Forensic Medicine 164
- Immunology 122
Countries citing papers authored by David Remillard
This map shows the geographic impact of David Remillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Remillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Remillard more than expected).
Fields of papers citing papers by David Remillard
This network shows the impact of papers produced by David Remillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Remillard. The network helps show where David Remillard may publish in the future.
Co-authors
The 25 scholars most cited alongside David Remillard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 314 | |
| 2 | 2020 | 266 | |
| 3 | 2017 | 261 | |
| 4 | 2018 | 170 | |
| 5 | 2022 | 95 | |
| 6 | 2023 | 47 | |
| 7 | 2022 | 30 | |
| 8 | 2023 | 23 | |
| 9 | 2016 | 16 | |
| 10 | 2019 | 14 | |
| 11 | 2021 | 8 |
About David Remillard
David Remillard is a scholar working on Hematology, Molecular Biology, Physiology, Oncology and Pathology and Forensic Medicine, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (5 papers), Multiple Myeloma Research and Treatments (5 papers), Chromatin Remodeling and Cancer (2 papers), RNA Research and Splicing (2 papers), Cancer-related gene regulation (2 papers), Peptidase Inhibition and Analysis (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Molecular Biology (1.1k citations), Hematology (164 citations), Oncology (270 citations), Pathology and Forensic Medicine (164 citations) and Immunology (122 citations). David Remillard has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include James E. Bradner, Gerard L. Brien, Scott A. Armstrong, Nathanael S. Gray, Hyuk‐Soo Seo, Dennis L. Buckley, Sirano Dhe‐Paganon, Matthew Sonnett, Joshiawa Paulk and Shiva Dastjerdi. Their work appears in journals such as Angewandte Chemie International Edition, ACS Chemical Biology, Journal of the American Chemical Society, Science Advances and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.